Abstract

Obscurins comprise a family of proteins originally identified in striated muscles, where they play essential roles in myofibrillogenesis, cytoskeletal organization, and Ca2+ homeostasis. They are encoded by the single OBSCN gene, and are composed of tandem adhesion domains and signaling motifs. To date, two giant obscurin isoforms have been described in detail that differ only at the extreme COOH-terminus; while obscurin-A (∼720 kDa) contains a non-modular COOH-terminus that harbors binding sites for the adaptor proteins ankyrins, obscurin-B (∼870 kDa) contains two COOH-terminal serine-threonine kinase domains preceded by adhesion motifs. Besides the two known giant obscurins, a thorough search of transcript databases suggests that complex alternative splicing of the obscurin transcript results in the generation of additional giant as well as small isoforms with molecular masses ranging between ∼50–970 kDa. These novel isoforms share common domains with the characterized isoforms, but also contain unique regions. Using a panel of highly specific antibodies directed against epitopes spanning the entire length of giant obscurins, we employed western blotting and immunohistochemistry to perform a systematic and comprehensive characterization of the expression profile of obscurins in muscle and non-muscle tissues. Our studies demonstrate for the first time that obscurins are not restricted to striated muscles, but are abundantly expressed in several tissues and organs including brain, skin, kidney, liver, spleen, and lung. While some obscurin isoforms are ubiquitously expressed, others are preferentially present in specific tissues and organs. Moreover, obscurins are present in select structures and cell types where they assume nuclear, cytosolic, and membrane distributions. Given the ubiquitous expression of some obscurins, along with the preferential expression of others, it becomes apparent that obscurins may play common and unique roles, respectively, in the regulation and maintenance of cell homeostasis in various tissues and organs throughout the body.

Highlights

  • Obscurin was originally discovered about a decade ago during a yeast two-hybrid screen as a binding partner of the giant protein titin [1]

  • Namely obscurin-A and obscurin-B, share common domain architectures. They are composed of 68 immunoglobulin (Ig) and 3 fibronectin type-III (FNIII) adhesion domains, along with several signaling motifs, including an isoleucine-glutamine (IQ) calmodulin-binding motif, a src-homology 3 (SH3) domain, and tandem Rho-guanine nucleotide exchange factor (RhoGEF) and pleckstrin homology (PH) motifs

  • Obscurin-B (,870 kDa; Fig. 1B) lacks the non-modular COOH-terminal region found in obscurin-A, but includes two serine/threonine kinase (SK) domains that belong to the myosin light chain kinase (MLCK) subfamily, and are referred to as serine/threonine kinase 2 (SK2) and SK1 [2]

Read more

Summary

Introduction

Obscurin was originally discovered about a decade ago during a yeast two-hybrid screen as a binding partner of the giant protein titin [1]. In accordance with previous studies, mouse and rat striated muscles express obscurin-A- and B-like isoforms

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call